Libero Pharma
UEI: KDK7WQD2CZQ7
• CAGE: U1R72
Overview
Awardee Type
Parent
Name
Libero Pharma
Website
Headquarters
Edinburgh
United Kingdom
United Kingdom
Most Recent Award
Sept. 30, 2022
Calculating
Federal grant recipient
LIBERO PHARMA LIMITED
(UEI KDK7WQD2CZQ7, CAGE U1R72)
is headquartered in Edinburgh .
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The international organization
was founded in December 2018 and
federally registered in
December 2020.
Federal Award Analysis
Libero Pharma federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
LIBERO PHARMA LIMITED
UEI
KDK7WQD2CZQ7
CAGE Code
U1R72
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
International Organization
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 5, 2018
Initial Registration
Dec. 2, 2020
Last Registration
July 10, 2025
Registration Activation
July 10, 2025
Registration Expiration
July 10, 2026
Fiscal Year End
February 28
Reported Entity Types
For Profit Organization
Country of Incorporation
GBR
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No